Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet ...
Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...
WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the development of a first-in-class platelet function assay that measures phosphorylation of ...
An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...
Use of platelet reactivity testing in ACS patients coming off P2Y12 inhibitors who may be at risk for perioperative bleeding can safely shorten the waiting time before CABG, potentially cutting ...
ROME, ITALY — Monitoring platelet function and individualizing antiplatelet therapy did not improve outcomes for elderly ACS patients undergoing coronary stenting, results of the ANTARCTIC trial show ...
The MarketWatch News Department was not involved in the creation of this content. WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results